Literature DB >> 25438393

Factors affecting the success of influenza laboratory diagnosis.

Renáta Kissová, Marek Svitok, Cyril Klement, Lucia Mad'arová.   

Abstract

Influenza is one of the most common human infectious diseases, and has profound health and economic consequences. The laboratory diag- nosis of influenza virus infections plays an important role in the global surveillance of influenza. Therefore, there is a growing demand for highly sensitive and rapid methods for detecting influenza. The performance of particular diagnostic methods is affected by various factors. In this study, we assess the effects of patients' age and time to diagnosis on the probability of detecting influenza using four diagnostic methods (virus isolation, rapid test, RT-PCR and real-time RT-PCR). We examined 3,546 samples from central and eastern Slovakia during the influenza seasons from 2005-2006 to 2010-2011. In general, the probability of influenza detection significantly decreased with the time from onset of illness to sample collection (T1) as well as with patients' age (AGE). On the contrary, time from sample collection to delivery (T2) did not play a role in the prob- ability of influenza detection. As judged by odds ratios, the virus isolation method was most sensitive to T1, followed by the rapid test and RT-PCR methods. For the effect of AGE, the rapid test and virus isolation methods were more sensitive than PCR-based methods. The effects of T1 and AGE were independent of each other. Laboratories which participate in inifluenza surveillance should use several methods to enable rapid and accurate influenza A and B virus detection.

Entities:  

Mesh:

Year:  2014        PMID: 25438393     DOI: 10.21101/cejph.a3906

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  1 in total

1.  Respiratory Virus Infections in People Over 14 Years of Age in Poland in the Epidemic Season of 2017/18.

Authors:  K Szymański; K Łuniewska; E Hallmann-Szelińska; D Kowalczyk; R Sałamatin; A Masny; L B Brydak
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.